Abstract
THE pronounced response by mouse T cells to the major histocom-patibility complex (MHC) class I antigens of the same species is characterized by a relatively large fraction of responding cells (reviewed in ref. 1). Responses to MHC class I allelles of other species are, however, generally much weaker2–5. T lymphocytes are positively selected on thymic MHC antigens, resulting in a T-cell repertoire with strong alloreactivity6. This has been explained in terms of a mouse T-cell repertoire that is not efficiently selected for recognition of HLA molecules owing to the absence of HLA in mice. Here we show that mice transgenic for HLA mount a T-cell response against allogeneic HLA that is no better than in normal mice. We decided instead to test whether the mouse accessory molecule Lyt-2 on cytotoxic T lymphocytes could interact efficiently with the α3 domain of HLA. To do this, we replaced the α3 domain of HLA-B27 by a murine α3 domain in a gene construct used to produce transgenic mice, and then used the spleen cells from these mice to stimulate normal mouse T cells. Under these conditions cytotoxic T lymphocytes were generated with the same frequency against xenogeneic HLA-B27 determinants as against allogeneic mouse class I antigens. These findings indicate that the normally weak xeno-MHC response is due to the inefficient interaction of the murine Lyt-2 accessory molecule with HLA class I, and not to limitations of the mouse T-cell repertoire.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dutton, R. W., Panfili, P. R. & Swain, S. L. Immunol. Rev. 42, 20–58 (1978).
Wilson, D. B. & Fox, D. H. J. exp. Med. 134, 857–870 (1971).
Widmer, M. B. & Bach, F. H. J. exp. Med. 135, 1204–1208 (1972).
Hines, D. L., Cowall, C. & Lang, R. W. Transplantation 21, 375–380 (1976).
Engelhard, V. H., Strominger, J. L. Mescher, M. & Burakoff, S. J. Proc. natn. Acad. Sci. U.S.A. 75, 5688–5691 (1978).
Teh, H. S. et al. Nature 335, 229–233 (1988).
Kievits, F., Wijffels, J., Lokhorst, W. & Ivanyi, P. Proc. natn. Acad. Sci. U.S.A. 86, 617–620 (1989).
Hämmerling, G. J., Hunt, T., Dill, O. & Moreno, J. Eur. J. Immun. 19, 599–604 (1989).
Shimonkevitz, R., Luescher, B., Cerottini, J.-C. & MacDonald, H. R. J. Immun. 135, 892–899 (1985).
Dembic, Z. et al. Nature 326, 510–511 (1987).
Gabert, J. et al. Cell 50, 545–554 (1987).
Potter, T. A., Bluestone, J. A. & Rajan, T. V. J. exp. Med. 166, 956–966 (1987).
Maziarz, R. T., Burakoff, S. J. & Bluestone, J. A. J. Immun. 140, 4372–4377 (1988).
Connolly, J. M., Hansen, T. H., Ingold, A. L. & Potter, T. A. Proc. natn. Acad. Sci. U.S.A. 87, 2137–2141 (1990).
Salter, R. D. et al. Nature 338, 345–347 (1989).
Salter, R. D. et al. Nature 345, 41–46 (1990).
Arnold, B. et al. Cell 38, 79–87 (1984).
Ozato, K., Evans, G. A., Shykind, B., Margulies, D. H. & Seidman, J. G. Proc. natn. Acad. Sci. U.S.A 80, 2040–2043 (1983).
Krimpenfort, P. et al. EMBO J. 6, 1673–1676 (1987).
Bjorkman, P. J. et al. Nature 329, 506–512 (1987).
Samberg, N. L., Scarlett, E. C. & Stauss, H. J. Eur. J. Immun. 19, 2349–2354 (1989).
Irwin, M. J., Heath, W. R. & Sherman, L. A. J. exp. Med. 170, 1091–1101 (1989).
Alter, B. J. & Bach, F. H. J. exp. Med. 171, 333–338 (1990).
Dill, O., Kievits, F., Koch, S., Ivanyi, P. & Hämmerling, G. J. Proc. natn. Acad. Sci. U.S.A. 85, 5664–5668 (1988).
Coppin, H. L. & McDevitt, H. O. J. Immun. 137, 2168–2172 (1986).
Arnold, B., Archibald, A., Burgert, H.-B. & Kvist, S. Nucleic Acids Res. 12, 9473–9487 (1984).
Koller, B. H. & Orr, H. T. J. Immun. 134, 2727–2733 (1985).
Ledbetter, J. A. & Herzernberg, L. A. Immunol. Rev. 47, 63–89 (1979).
Rebai, N. & Malissen, B. Tissue Antigens 22, 107–117 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalinke, U., Arnold, B. & Hämmerling, G. Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA B27. Nature 348, 642–644 (1990). https://doi.org/10.1038/348642a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/348642a0
This article is cited by
-
Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice
Archives of Toxicology (2018)
-
Immunological aspects of cellular transplantology
Bulletin of Experimental Biology and Medicine (1998)
-
Co-engagement of CD8 with the T cell receptor is required for negative selection
Nature (1991)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.